Carotid Intima Media Thickness (CIMT) as a Cardiovascular Risk Factor | As part of our ongoing commitment to provide the latest advancements in preventative medicine, Cenegenics is now offering an additional, state of the art, screening tool for vascular disease called CIMT.
Seeing as heart disease is the number one killer, there’s simply nothing more important than your heart. One in four fatalities are caused by heart events , and traditional medicine mischaracterized 50% of patients as “low risk” who later went on to experience a heart event .
By focusing on prevention and effective treatment methods, our thorough testing goes far beyond what is considered “standard” in the medical community.
The carotid arteries (located on either side of your neck) are what supply your brain with blood, it’s one of the most important arteries in your body. Examining them can uncover critical information, leading to proper diagnosis and treatment. For example, chronic inflammation could point to an autoimmune disorder or other underlying conditions. This relatively non-invasive exam can go along way in overall prevention and treatment mapping.
The CIMT Test is an FDA-approved, advanced ultrasound evaluation of your carotid arteries. It aids in the detection of existing plaque and provides an extremely precise measurement of your artery wall thickness. When your artery wall thickens, it can be an early sign of vascular disease, increasing your risk of heart attack and stroke. Instead of waiting for these life-threatening events to take place-- Cenegenics provides a preventive measure of protection that can dramatically change the outcome of your life.
Cenegenics can provide powerful insights into your cardiovascular health. Along with CIMT and other specialized heart health testing, we can provide you with the best chance of living a life free of heart disease.
CIMT can assess cardiovascular risk in asymptomatic patients. Cardiovascular disease is one of the leading causes of death globally. To assess risk, doctors typically review traditional risk factors, such as total cholesterol, blood pressure, smoking history, age, gender, lipid profile (HDL/LDL levels), and family history. However, these conventional tests can be poor predictors of future atherothrombotic events. Relying on these factors may result in misclassification of risk. In a major study of 136,905 patients hospitalized with coronary artery disease, only 23% had high LDL levels* (above 130 mg/dl) and would be identified by traditional risk factors. Yet in a large outcome study of 10,000 asymptomatic subjects with a 10 year follow-up (mean age = 53), ultrasound identified 98.6% of future atherothrombotic events.**
*Sachdeva et al. AHJ, Vol 157, 111-117, Jan 2009
**Belcaro G, et al. Atherosclerosis 2001; 156: 379-387
In most cases, the entire test takes no longer than five minutes, allowing you instant access to extremely important results. A detailed report is generated based on traditional risk factor scores (FRAMINGHAM, SCORE or PROCAM) and the results of the ultrasound examination. Combining these two reports yields the clearest overall picture of your heart health.
 Heart Disease Facts, Centers for Disease Control and Prevention, n.d.
 From Vulnerable Plaque to Vulnerable Patient—Part III: Executive Summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force Report, The American Journal of Cardiology, 2006.
Our team is ready to provide you with an incredible experience!